IMRIS Inc. (NASDAQ: IMRS) shares gained 1.5% to $1.35 after a study published this month in the journal Neurosurgery by the neurosurgical team at Cleveland Clinic adds to growing clinical evidence which validates use of high-field intraoperative MRI as an effective tool for maximizing the amount of surgical resection of brain tumors. Share volume was 25,000, compared to an all-day average of 366,000
